Bempedoic Acid

Catalog NumberPI738606467

CAS Number738606-46-7

CategoryEndocrinology & Metabolism

Bempedoic Acid API is a novel small molecule inhibitor of triphosphate-citrate lyase (ACL). It is indicated as an adjunctive therapy, along with diet and statin treatment, for adults with refractory hypercholesterolemia. By blocking cholesterol synthesis in the liver, Bacid effectively reduces LDL-C levels, mitigating the risk of atherosclerotic plaques and cardiovascular events. It was approved for use by the FDA in 2020, along with a combination product Bempedoic Acid and Ezetimibe.